RAPT Therapeutics to Participate in Upcoming Investor Conferences
RAPT Therapeutics (Nasdaq: RAPT), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, has announced its participation in two major investor conferences in March 2025. The company, which focuses on developing treatments for inflammatory and immunological diseases, will be featured in:
- The Leerink Global Healthcare Conference with a fireside chat scheduled for March 11, 2025 at 3:40 p.m. ET
- The Barclays 27th Annual Global Healthcare Conference with a fireside chat planned for March 12, 2025 at 10:30 a.m. ET
Interested parties can access live webcasts and archived recordings of these discussions through the company's investor relations website at investors.rapt.com/events-and-presentations.
RAPT Therapeutics (Nasdaq: RAPT), un'azienda biofarmaceutica in fase clinica specializzata in terapie basate sull'immunologia, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel marzo 2025. L'azienda, che si concentra sullo sviluppo di trattamenti per malattie infiammatorie e immunologiche, sarà presente in:
- La Leerink Global Healthcare Conference con una chiacchierata informale programmata per l'11 marzo 2025 alle 15:40 ET
- La Barclays 27th Annual Global Healthcare Conference con una chiacchierata informale prevista per il 12 marzo 2025 alle 10:30 ET
Le parti interessate possono accedere a webcast dal vivo e registrazioni archiviate di queste discussioni attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.rapt.com/events-and-presentations.
RAPT Therapeutics (Nasdaq: RAPT), una empresa biofarmacéutica en etapa clínica especializada en terapias basadas en inmunología, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025. La compañía, que se centra en el desarrollo de tratamientos para enfermedades inflamatorias e inmunológicas, estará presente en:
- La Leerink Global Healthcare Conference con una charla informal programada para el 11 de marzo de 2025 a las 3:40 p.m. ET
- La Barclays 27th Annual Global Healthcare Conference con una charla informal prevista para el 12 de marzo de 2025 a las 10:30 a.m. ET
Las partes interesadas pueden acceder a transmisiones web en vivo y grabaciones archivadas de estas discusiones a través del sitio web de relaciones con inversores de la empresa en investors.rapt.com/events-and-presentations.
RAPT Therapeutics (Nasdaq: RAPT), 면역학 기반 치료를 전문으로 하는 임상 단계의 생명공학 회사가 2025년 3월 두 개의 주요 투자자 회의에 참여할 것이라고 발표했습니다. 염증 및 면역 질환 치료 개발에 주력하는 이 회사는 다음과 같은 행사에 참여할 예정입니다:
- Leerink Global Healthcare Conference에서 2025년 3월 11일 오후 3시 40분 ET에 예정된 대화형 세션
- Barclays 27th Annual Global Healthcare Conference에서 2025년 3월 12일 오전 10시 30분 ET에 예정된 대화형 세션
관심 있는 분들은 회사의 투자자 관계 웹사이트인 investors.rapt.com/events-and-presentations를 통해 이러한 논의의 라이브 웹캐스트 및 아카이브된 녹음에 접근할 수 있습니다.
RAPT Therapeutics (Nasdaq: RAPT), une entreprise biopharmaceutique en phase clinique spécialisée dans les thérapies basées sur l'immunologie, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025. L'entreprise, qui se concentre sur le développement de traitements pour les maladies inflammatoires et immunologiques, sera présente lors des événements suivants :
- La Leerink Global Healthcare Conference avec une discussion informelle prévue le 11 mars 2025 à 15h40 ET
- La Barclays 27th Annual Global Healthcare Conference avec une discussion informelle prévue le 12 mars 2025 à 10h30 ET
Les parties intéressées peuvent accéder aux webinaires en direct et aux enregistrements archivés de ces discussions via le site Web des relations avec les investisseurs de l'entreprise à l'adresse investors.rapt.com/events-and-presentations.
RAPT Therapeutics (Nasdaq: RAPT), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf immunologische Therapien spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 bekannt gegeben. Das Unternehmen, das sich auf die Entwicklung von Behandlungen für entzündliche und immunologische Erkrankungen konzentriert, wird an folgenden Veranstaltungen teilnehmen:
- Der Leerink Global Healthcare Conference mit einem informellen Gespräch, das für den 11. März 2025 um 15:40 Uhr ET geplant ist
- Der Barclays 27th Annual Global Healthcare Conference mit einem informellen Gespräch, das für den 12. März 2025 um 10:30 Uhr ET geplant ist
Interessierte Parteien können über die Website der Investorenbeziehungen des Unternehmens unter investors.rapt.com/events-and-presentations auf Live-Webcasts und archivierte Aufzeichnungen dieser Diskussionen zugreifen.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in March:
- Leerink Global Healthcare Conference – Fireside chat on Tuesday, March 11, 2025 at 3:40 p.m. ET
- Barclays 27th Annual Global Healthcare Conference – Fireside chat on Wednesday, March 12, 2025 at 10:30 a.m. ET
To access the live webcasts or subsequent archived recordings of the discussions, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.
RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com
RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com
FAQ
When is RAPT Therapeutics presenting at the Leerink Global Healthcare Conference in March 2025?
What type of conferences will RAPT Therapeutics attend in March 2025?
How can investors access RAPT Therapeutics' conference presentations?
What is RAPT Therapeutics' current development focus in 2025?
